Platelet News and Research

RSS

Emerging Healthcare Solutions issues Term Sheet review to ThromboVision

Emerging Healthcare Solutions, Inc. announced today that management has formally delivered an actionable Term Sheet to ThromboVision for review and that follow up communications have been very favorable.

9 Feb 2010

Risk of heart attack greater in women with gout

Women with gout are at greater risk of a heart attack than men with the disease, indicates research published ahead of print in the Annals of the Rheumatic Diseases.

7 Feb 2010

Emerging Healthcare Solutions completes due diligence and review requirements with ThromboVision

Emerging Healthcare Solutions, Inc. announced today that the company has successfully completed the due diligence and review requirements under their recent option agreement with ThromboVision, a company that has licensed the patent on the new T-Guide® Platelet Function Analyzer, which is currently going through regulatory clearance review.

4 Feb 2010

EPO to grant patent notice to BioMimetic Therapeutics

BioMimetic Therapeutics, Inc. announced today the European Patent Office (EPO) intends to grant patent application No. 05803356 titled “Platelet-Derived Growth Factor Compositions and Methods of Use Thereof”.

2 Feb 2010

GMC designated as NMDP collection site to collect bone marrow from willing donors

Geisinger Medical Center (GMC) was recently designated a National Marrow Donation Program (NMDP) collection site, becoming the only site in the region to collect bone marrow or blood stem cells from willing donors.

2 Feb 2010

Sports Medicine Clinic offers PRP therapy to heal injured ligaments, tendons and muscles

The Sports Medicine Clinic at the University of Virginia Health System is using a cutting-edge therapy called platelet rich plasma (PRP) to help heal injured ligaments, tendons and muscles.

29 Jan 2010

Discovery challenges understanding of blood cell development

University of Utah researchers led an international team of scientists that is the first to report on the previously undescribed ability of platelets to reproduce themselves in the circulation. Their revolutionary findings were published online Jan. 19, 2010, in the journal Blood.

27 Jan 2010

Researching treatments shows paths to health savings

An orthopedic surgeon in Sacramento became suspicious of a new therapy that helps tendons heal by injecting platelet-rich plasma into joints, The Sacramento Bee reports. So, he decided to do a test. It turned out, his patients outcomes were no different when he used the platelet-rich plasma therapy as when he didn't. The plasma treatment costs hundreds of dollars more per patient.

27 Jan 2010

Emerging Healthcare Solutions and ThromboVision complete due diligence process under new option agreement

Emerging Healthcare Solutions, Inc. and ThromboVision have completed phase one of their due diligence process under their new option agreement.

21 Jan 2010

Statins may protect SCD children from pneumococcal infection

New research suggests a family of widely used cholesterol-lowering drugs might help protect individuals from serious illness following bacterial infection, including the pneumococcal infections that pose a deadly threat to those with sickle cell disease.

20 Jan 2010

Cerus' INTERCEPT platelets therapeutically effective even after seven days of storage

Cerus Corporation announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a clinical study conducted at four sites in Europe. These data further confirm the safety and therapeutic efficacy of platelets treated with the INTERCEPT Blood System, a pathogen inactivation treatment designed to protect against transfusion-transmitted diseases.

18 Jan 2010

PRP injections are ineffective for treating Achilles tendon disorder

An apparently increasingly used treatment method for a type of Achilles tendon disorder that includes injection of platelet-rich plasma into the tendon does not appear to result in greater improvement in pain or activity compared to placebo, according to results of a preliminary study published in the January 13 issue of JAMA.

13 Jan 2010

PDGFR's role in new blood vessel formation may explain cardiovascular side effects

A growth factor that is a common target of cancer drugs also plays an important role in the heart's response to stress, researchers at The University of Texas M. D. Anderson Cancer Center report online this week in the Journal of Clinical Investigation.

12 Jan 2010

Emerging Healthcare Solutions seeks business opportunities with new, patented T-Guide Platelet Function Analyzer

Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.

8 Jan 2010

Eisai acquires AkaRx for approximately $255 million

Eisai Inc. (Headquarters: Woodcliff Lake, New Jersey, Chairman and CEO: Hajime Shimizu, "Eisai") today announces the successful completion of its acquisition of the biopharmaceutical company, AkaRx, Inc. (Headquarters: Bridgewater, New Jersey, CEO: Robert E. Desjardins), for approximately $255 million.

6 Jan 2010

Emerging Healthcare Solutions to execute option agreement with ThromboVision

Emerging Healthcare Solutions, Inc. is pleased to announce the execution of an exclusive option agreement with ThromboVision, Inc. ThromboVision, a Houston-based healthcare diagnostics company committed to enabling people to lead longer and healthier lives, has developed and patented T-Guide®, a new cutting-edge diagnostic test to assist medical professionals with the treatment of heart disease.

29 Dec 2009

PGxHealth, DHZ announce collaboration in genetic variant study with response to clopidogrel

PGxHealth, a division of Clinical Data, Inc., today announced that it has established a research collaboration with Deutsches Herzzentrum (DHZ), Munich, Germany, to evaluate the predictive value of genetic markers, including PGxHealth proprietary markers, for response to clopidogrel (Plavix®).

22 Dec 2009

GSK receives European CHMP positive opinion for Revolade

Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has received a positive opinion for Revolade® (eltrombopag/Promacta®) from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for the oral treatment of thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP).

18 Dec 2009

Regado Biosciences announces completion of Series D financing

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic therapeutic aptamers with active control agents, today announced the completion of a $40 million Series D financing.

18 Dec 2009

Treprostinil drug reduces breathlessness in PAH patients, says study

Patients with a rare, deadly disease that mostly affects young women felt a dramatic reduction in breathlessness using an approved drug, according to study results published online today in The Journal of Heart and Lung Transplantation.

18 Dec 2009

Platelet News and Research

Emerging Healthcare Solutions issues Term Sheet review to ThromboVision

Risk of heart attack greater in women with gout

Emerging Healthcare Solutions completes due diligence and review requirements with ThromboVision

EPO to grant patent notice to BioMimetic Therapeutics

GMC designated as NMDP collection site to collect bone marrow from willing donors

Sports Medicine Clinic offers PRP therapy to heal injured ligaments, tendons and muscles

Discovery challenges understanding of blood cell development

Researching treatments shows paths to health savings

Emerging Healthcare Solutions and ThromboVision complete due diligence process under new option agreement

Statins may protect SCD children from pneumococcal infection

Cerus' INTERCEPT platelets therapeutically effective even after seven days of storage

PRP injections are ineffective for treating Achilles tendon disorder

PDGFR's role in new blood vessel formation may explain cardiovascular side effects

Emerging Healthcare Solutions seeks business opportunities with new, patented T-Guide Platelet Function Analyzer

Eisai acquires AkaRx for approximately $255 million

Emerging Healthcare Solutions to execute option agreement with ThromboVision

PGxHealth, DHZ announce collaboration in genetic variant study with response to clopidogrel

GSK receives European CHMP positive opinion for Revolade

Regado Biosciences announces completion of Series D financing

Treprostinil drug reduces breathlessness in PAH patients, says study

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News